Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
Summary Interpretation The most defensible interpretation is that 5-Amino-1MQ is a small-molecule NNMT inhibitor that has been used in published preclinical research models without prominent severe acute toxicological signals described in the cited preclinical model reports under their specific tested conditions
Overview 5-Amino-1MQ Peptide is supplied as a research-grade catalog material for controlled laboratory investigation
It is a single peptide (with 39 amino acids) conjugated to a lipid diacid molecule
Injectable research protocols commonly reference GHK-Cu doses in the range of 1-2mg per administration, administered once daily or several times per week depending on the research design
semaglutide alone 14.9%, cagrilintide alone 11.5%, placebo 3.0%
US$ 20.43
US$ 20.83
US$ 29.47
US$ 22.50
US$ 24.60
